Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 42.83%9.41B | 40.81%6.59B | 78.53%2.36B | 24.83%1.45B | 24.72%1.38B | 28.42%1.4B | 21.94%4.68B | 25.99%1.32B | 16.19%1.16B | 21.82%1.11B |
| Cost of revenue | 119.93%3.29B | 355.05%1.49B | 424.00%890.8M | 242.41%187.86M | 329.75%195.47M | 279.47%220.38M | -92.45%328.43M | -85.50%170M | -94.19%54.86M | -95.97%45.48M |
| Gross profit | 20.21%6.12B | 17.09%5.09B | 27.56%1.47B | 14.04%1.26B | 11.64%1.18B | 14.28%1.18B | 944.32%4.35B | 1,037.73%1.15B | 1,886.97%1.11B | 581.26%1.06B |
| Operating expense | 22.51%5.87B | 6.98%4.79B | 38.49%1.46B | -2.62%1.15B | 10.81%1.1B | -13.63%1.08B | 4.48B | 1.06B | 1.18B | 988.53M |
| Operating profit | -15.96%256.12M | 341.14%304.78M | -94.73%4.99M | 257.72%114.01M | 23.12%88.68M | 144.01%97.1M | 75.47%-126.39M | 176.94%94.53M | -229.76%-72.28M | 132.68%72.03M |
| Net non-operating interest income (expenses) | -174.28%-9.77M | -1,970.35%-3.56M | -9,159.46%-3.43M | 0.00%-49K | -2.70%-38K | 2.04%-48K | 14.85%-172K | 0.00%-37K | 3.92%-49K | -5.71%-37K |
| Non-operating interest income | 1,135.59%4.93M | 1,377.78%399K | 2,853.85%384K | 100.00%2K | -7.69%12K | --1K | 0.00%27K | 0.00%13K | --1K | -7.14%13K |
| Non-operating interest expense | 271.14%14.7M | 1,889.95%3.96M | 7,520.00%3.81M | 2.00%51K | 0.00%50K | 0.00%49K | -13.10%199K | 0.00%50K | -1.96%50K | 2.04%50K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 63.26%-31.41M | -72.73%-85.5M | 0 | -55.5M | -30M | 0 | -65.00%-49.5M | 0 | 0 | 0 |
| Income from associates and other participating interests | 0.48%-207K | -208K | 0 | |||||||
| Special income (charges) | 107.94%4.4M | -542.76%-55.35M | -55.35M | 0 | 177.78%12.5M | 0 | 0 | 0 | ||
| Less:Other special charges | -107.94%-4.4M | 542.76%55.35M | ---- | ---- | ---- | ---- | -177.78%-12.5M | --0 | --0 | --0 |
| Other non-operating income (expenses) | -33.75%6.73M | 30.58%10.16M | 4,244.26%10.11M | -135.98%-819K | -211.20%-2.88M | 18.56%3.75M | 84.83%7.78M | -109.78%-244K | 157.47%2.28M | 4,215.00%2.59M |
| Income before tax | 32.61%225.87M | 209.34%170.33M | -146.56%-43.88M | 182.27%57.64M | -25.23%55.76M | 139.60%100.8M | 70.98%-155.78M | 162.66%94.25M | -214.78%-70.06M | 133.85%74.58M |
| Income tax | -152.87%-34.04M | 285.83%64.39M | -316.06%-25.48M | 4,978.95%26.06M | 919.81%38.87M | 4,262.06%24.95M | 596.83%16.69M | 1,644.53%11.79M | -10.31%513K | 562.78%3.81M |
| Net income | 145.35%259.91M | 161.42%105.93M | -122.32%-18.4M | 144.76%31.59M | -76.12%16.9M | 129.73%75.85M | 68.01%-172.47M | 154.58%82.45M | -216.72%-70.57M | 132.03%70.77M |
| Net income continuous operations | 145.35%259.91M | 161.42%105.93M | -122.32%-18.4M | 144.76%31.59M | -76.12%16.9M | 129.73%75.85M | 68.01%-172.47M | 154.58%82.45M | -216.71%-70.57M | 132.03%70.77M |
| Noncontrolling interests | 65.89%-47M | -42.68%-137.78M | -159.91%-21.63M | -503.71%-69.53M | -196.23%-38.3M | 86.95%-8.33M | -115.51%-96.57M | 78.56%-8.32M | -150.59%-11.52M | -12.93M |
| Net income attributable to the company | 25.93%306.9M | 421.11%243.72M | -96.44%3.23M | 271.22%101.11M | -34.06%55.19M | 144.00%84.18M | 84.65%-75.9M | 180.86%90.78M | -190.77%-59.06M | 138.13%83.7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 25.93%306.9M | 421.11%243.72M | -96.44%3.23M | 271.22%101.11M | -34.06%55.19M | 144.00%84.18M | 84.65%-75.9M | 180.86%90.78M | -190.77%-59.06M | 138.13%83.7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 28.01%13.07 | 419.06%10.21 | -96.61%0.13 | 270.28%4.24 | -35.29%2.31 | 143.53%3.53 | 84.96%-3.2 | 180.46%3.83 | -184.41%-2.49 | 137.86%3.57 |
| Diluted earnings per share | 27.70%12.77 | 412.50%10 | -96.59%0.13 | 266.27%4.14 | -34.34%2.3097 | 143.53%3.53 | 84.96%-3.2 | 179.88%3.8084 | -189.88%-2.49 | 137.30%3.5176 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |